MicroPort CardioFlow secures CE mark for balloon catheter

MicroPort CardioFlow Medtech Corporation announced its Alwide Plus balloon catheter has received CE Mark approval for the European market. The product is designed to dilate calcified aortic valves before TAVI procedures.

Following approval in China in August 2021, Alwide Plus has secured registrations in over 10 overseas countries. The CE Mark approval is expected to contribute to the company's overseas revenue growth.

This marks the fourth independently developed product by MicroPort CardioFlow to receive CE Mark approval, strengthening its presence in the European structural heart disease market.